Skip to content

Clinical trials

Observational Hyperlipoproteinemia Type II trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Phase: Observational Status: Unknown status Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20162
20174
20181
20192
20201
20215

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Isfahan University of Medical Sciences2
Assistance Publique - Hôpitaux de Paris1
Assiut University1
Centre Hospitalier du Luxembourg1
China Cardiovascular Association1
Federico II University1
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)1
Imperial College London Diabetes Centre1
Institute of Cardiometabolism and Nutrition, France1
Institute of Health Information and Statistics of the Czech Republic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II19
Atherosclerosis3
Cardiovascular Diseases3
Acute Coronary Syndrome1
Aortic Valve Stenosis1
Arteriosclerosis1
Calcinosis1
Genetic Diseases, Inborn1
Homozygous Familial Hypercholesterolemia1
Hypercholesterolemia1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.